# FGFR2 is a Crucial Factor for Adipose‐Derived Mesenchymal Stem Cells in Promoting Diabetic Foot Ulcer Healing Through Angiogenesis

**Authors:** Jing Cao, Zichao Liu, Wenqiang An, Xin Zhang, Zhujun Li, Lijie Li, Hailian Ji, Sen Zhang, Xiao Long, Yuemei Yang

PMC · DOI: 10.1111/jcmm.70942 · Journal of Cellular and Molecular Medicine · 2025-11-13

## TL;DR

This study shows that FGFR2 in fat-derived stem cells helps heal diabetic foot ulcers by promoting blood vessel growth.

## Contribution

The study identifies FGFR2 as a key driver of angiogenesis in ADSCs for diabetic foot ulcer healing.

## Key findings

- FGFR2 upregulation and FGF secretion activate the FGF-PI3K/Akt-HIF-1α-VEGF axis to promote angiogenesis.
- ADSCs enhance wound healing by secreting VEGF and improving blood vessel formation in diabetic ulcers.
- Angiogenesis-related DEGs were enriched in pathways like extracellular matrix and collagen formation.

## Abstract

Diabetic foot ulcers (DFUs) remain a significant clinical challenge due to the lack of effective treatments, severely impacting patients' quality of life. Mesenchymal stem cells (MSCs) have shown potential in promoting DFU healing; however, the underlying mechanisms are not yet fully understood. This study investigates the role of adipose‐derived mesenchymal stem cells (ADSCs) in DFU healing, with a particular focus on angiogenesis. Gene expression profiles from the GSE7014 and GSE80178 datasets in the Gene Expression Omnibus (GEO) database were analyzed. Differentially expressed genes (DEGs) were intersected with angiogenesis‐related genes from the GeneCards database, identifying 35 angiogenesis‐related DEGs (An‐DEGs). Key genes were selected using Cytoscape software and machine learning. The pro‐angiogenic effects of ADSCs were validated through in vivo and in vitro experiments, assessing their role in DFU healing. The DEGs from DFU patients were enriched in pathways such as angiogenesis and collagen‐containing extracellular matrix. ADSCs promoted angiogenesis and wound healing by upregulating FGFR2 and secreting FGF, activating the FGF‐PI3K/Akt‐HIF‐1α‐VEGF axis. Additionally, ADSCs mediated secretion of VEGF concerting this effect. FGFR2 plays a pivotal role in ADSCs' mediated DFU healing by driving angiogenesis.

## Linked entities

- **Genes:** FGFR2 (fibroblast growth factor receptor 2) [NCBI Gene 2263], VEGFA (vascular endothelial growth factor A) [NCBI Gene 7422], HIF1A (hypoxia inducible factor 1 subunit alpha) [NCBI Gene 3091]
- **Proteins:** FGF (fibroblast growth factor), VEGFA (vascular endothelial growth factor A)

## Full-text entities

- **Genes:** PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta) [NCBI Gene 5291] {aka P110BETA, PI3K, PI3KBETA, PIK3C1}, FGFR2 (fibroblast growth factor receptor 2) [NCBI Gene 2263] {aka BBDS, BEK, BFR-1, CD332, CEK3, CFD1}, HIF1A (hypoxia inducible factor 1 subunit alpha) [NCBI Gene 3091] {aka HIF-1-alpha, HIF-1A, HIF-1alpha, HIF1, HIF1-ALPHA, MOP1}, VEGFA (vascular endothelial growth factor A) [NCBI Gene 7422] {aka L-VEGF, MVCD1, VEGF, VPF}, AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207] {aka AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA}
- **Diseases:** DFUs (MESH:D017719), Diabetic (MESH:D003920)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12613079/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12613079/full.md

## References

48 references — full list in the complete paper: https://tomesphere.com/paper/PMC12613079/full.md

---
Source: https://tomesphere.com/paper/PMC12613079